Tardivex 40 mg Packaging
Click to zoom
DGDA Registration: DGDA Certified
Authentic Manufacturer Packaging
Capsule 40 mg

Tardivex

Manufactured by: Everest Pharmaceuticals Ltd.
Retail Price (MRP)
৳200.00 / unit
Pack: ৳2000.00 (1 x 10) Strip: ৳2000.00
Prescription Course & Cost Estimator
Estimate required Capsule count, strips, and pharmacy bill
Daily Dose:
/day
Duration:
days
Total Required Quantity 14 Capsules ~2 Strips (of 10 Capsules)
Estimated Prescription Bill ৳2800.00 ৳4000.00 for 2 full strips
View Basket 🛒

Cheaper & Alternative Brands

Same generic (Valbenazine Tosylate), same form (Capsule)

No other brands currently registered with this exact active generic and dosage form.

Clinical Prescribing Information

Medical monograph and safety information for healthcare professionals & patients.
📋

Indications & Clinical Uses

Tardivex is indicated for the treatment of adults with Tardive Dyskinesia.

Dosage & Administration

The initial dose is 40 mg once daily. After one week, increase the dose to the recommended dose of 80 mg once daily. Continuation of 40 mg once daily may be considered for some patients. Administer it orally with or without food.

Side Effects & Adverse Reactions

Somnolence, QT Prolongation

🛡️

Warnings & Precautions

Tardivex can cause somnolence. May impair the patient's ability to drive or operate hazardous machinery. Tardivex may prolong the QT interval. For patients who are CYP2D6-poor metabolizers or are taking a strong CYP2D6 inhibitor, dose reduction may be necessary. Avoid use in patients with congenital long QT syndrome or with arrhyth­mias associated with a prolonged QT interval. No dosage adjustment is necessary for patients with mild to moderate renal impairment. Use is not recommended in patients with severe renal impairment.

🔬

Pharmacology & Mechanism of Action

Valbenazine and its active metabolites bind to and inhibit vesicular monoamine transporter 2 (VMAT2) with high selectivity with no significant binding to VMAT1. This prevents the reuptake and storage of monoamine neurotransmitters noradrenaline, dopamine, and serotonin in synaptic vesicles making them vulnerable to metabolism by cytosolic enzymes. The presynaptic release of monoamine neurotransmitters is decreased due to the lack of vesicles with packaged neurotransmitters ready for release into the synapse. Neither valbenazine nor its active metabolite exhibits significant off-target binding at dopamine, serotonin, or adrenaline receptors.

Medical Disclaimer: The clinical monographs, pricing, and formulations on OshudBD are compiled for reference and informational purposes only. Always seek the advice of a registered physician regarding any medical treatment.
Tardivex ৳200.00 / unit
Search
Link copied to clipboard!